Aurora Spine Corporation (ASG)’in fiyatı nedir?

Aurora Spine Corporation (ASG)’in fiyatı $0.15779643’dir

Aurora Spine Corporation (ASG)’in piyasa değeri nedir?

Aurora Spine Corporation (ASG)’in piyasa değeri $12.32M’dir.

Aurora Spine Corporation (ASG) Faaliyet Marjı

Established in 2013 and headquartered in Toronto, Canada, Aurora Spine Corporation, through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spinal fusion systems and devices within the Canadian market. The company offers a comprehensive portfolio of products designed to address various spinal conditions, particularly degenerative disc diseases. This includes interspinous process lumbar fusion devices such as the ZIP series (ZIP, ZIP ULTRA, ZIP LP, and ZIP-51). Aurora Spine also provides Ti-Coated polyether ether ketone (PEEK) interbody cages, which are crucial for maintaining space and stability between vertebrae while facilitating bone fusion. Its offerings extend to sterile-packed titanium plasma spray coated spinal fusion implants that promote bone growth. Key interbody products comprise EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar region, and Discovery for cervical applications. The company also manufactures SOLO, an anterior lumbar interbody fusion (ALIF) 3D-printed stand-alone device featuring an integrated plate and spacer system for anatomical preservation and spinal support. For sacroiliac joint issues, Aurora Spine provides SiLo, a posterior fusion device. Furthermore, the DEXA-C cervical interbody system, a porous 3D-printed intervertebral body fusion device with customizable lattice density options, is available to match patient bone quality.

Yıl	Faaliyet Marjı	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Faaliyet Marjı

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Faaliyet Marjı	Faaliyet Marjı Farkı	Ülke
Abbott Laboratories ABT.US	17.03%	-	US
Stryker Corporation SYK.US	22.03%	-	US
Medtronic plc MDT.US	17.86%	-	IE
Boston Scientific Corporation BSX.US	21.46%	-	US
Edwards Lifesciences Corporation EW.US	28.09%	-	US

Şirket

Faaliyet Marjı

Faaliyet Marjı Farkı

Ülke